Research Opportunities in Optimizing Storage of Red Blood Cell Products

od Wagner, Stephen J., Glynn, Simone A., Welniak, Lisbeth A.
Izdano 2013

Immunomodulation and pharmacological strategies in the treatment of graft-versus-host disease

od Li, Minghui, Sun, Kai, Welniak, Lisbeth A., Murphy, William J.
Izdano 2008

Neuroendocrine Hormones such as Growth Hormone and Prolactin are Integral Members of the Immunological Cytokine Network

od Redelman, Doug, Welniak, Lisbeth A., Taub, Dennis, Murphy, William J.
izdano v Cell Immunol (2008)

Proteasome Inhibition and Allogeneic Hematopoietic Stem Cell Transplantation: A Review

od Koreth, John, Alyea, Edwin P., Murphy, William J., Welniak, Lisbeth A.
Izdano 2009

The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation

od Li, Minghui, Sun, Kai, Redelman, Doug, Welniak, Lisbeth A., Murphy, William J.
Izdano 2010

The Triterpenoid CDDO-Me Promotes Hematopoietic Progenitor Expansion and Myelopoiesis in Mice

od Ames, Erik, Harouna, Salif, Meyer, Colin, Welniak, Lisbeth A., Murphy, William J.
Izdano 2011

Differential effects of donor T-cell cytokines on outcome with continuous bortezomib administration after allogeneic bone marrow transplantation

od Sun, Kai, Li, Minghui, Sayers, Thomas J., Welniak, Lisbeth A., Murphy, William J.
Izdano 2008

Strategies for More Rapid Translation of Cellular Therapies for Children: A US Perspective

od Sanchez, Rosa, Silberstein, Leslie E., Lindblad, Robert W., Welniak, Lisbeth A., Mondoro, Traci Heath, Wagner, John E.
Izdano 2013

Providing researchers with online access to NHLBI biospecimen collections: The results of the first six years of the NHLBI BioLINCC program

od Giffen, Carol A., Wagner, Elizabeth L., Adams, John T., Hitchcock, Denise M., Welniak, Lisbeth A., Brennan, Sean P., Carroll, Leslie E.
izdano v PLoS One (2017)

Suppression of natural killer cell-mediated bone marrow cell rejection by CD4(+)CD25(+) regulatory T cells

od Barao, Isabel, Hanash, Alan M., Hallett, William, Welniak, Lisbeth A., Sun, Kai, Redelman, Doug, Blazar, Bruce R., Levy, Robert B., Murphy, William J.
Izdano 2006

Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation

od Welniak, Lisbeth A., Kuprash, Dmitry V., Tumanov, Alexei V., Panoskaltsis-Mortari, Angela, Blazar, Bruce R., Sun, Kai, Nedospasov, Sergei A., Murphy, William J.
Izdano 2006

Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-depende...

od Sun, Kai, Wilkins, Danice E. C., Anver, Miriam R., Sayers, Thomas J., Panoskaltsis-Mortari, Angela, Blazar, Bruce R., Welniak, Lisbeth A., Murphy, William J.
Izdano 2005

Regulatory and Conventional CD4(+) T cells Show Differential Effects Correlating with PD-1 and B7-H1 Expression After Immunotherapy

od Alderson, Kory L, Zhou, Qing, Berner, Vanessa, Wilkins, Danice EC, Weiss, Jonathan M, Blazar, Bruce R, Welniak, Lisbeth A, Wiltrout, Robert H, Redelman, Doug, Murphy, William J
Izdano 2008

The Synthetic Triterpenoid, CDDO, Suppresses Alloreactive T Cell Responses and Reduces Murine Early Acute Graft-versus-Host Disease Mortality

od Sun, Kai, Li, Minghui, Konopleva, Marina, Konoplev, Sergej, Stephens, L. Clifton, Kornblau, Steven M., Frolova, Olga, Wilkins, Danice E. C., Ma, Weihong, Welniak, Lisbeth A., Andreeff, Michael, Murphy, William J.
izdano v Biol Blood Marrow Transplant (2007)

IFN-γ Receptor Deficient Donor T cells Mediate Protection from Graft-versus-Host Disease and Preserve Graft-versus-Tumor Responses After Allogeneic Bone Marrow Transplantation

od Sun, Kai, Hsiao, Hui-Hua, Li, Minghui, Ames, Erik, Bouchlaka, Myriam, Welniak, Lisbeth A., Hagino, Takeshi, Jagdeo, Jared, Pai, Chien-Chun, Chen, Mingyi, Blazar, Bruce R., Abedi, Mehrdad, Murphy, William J.
Izdano 2012

Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib

od Sun, Kai, Welniak, Lisbeth A., Panoskaltsis-Mortari, Angela, O'Shaughnessy, Matthew J., Liu, Haiyan, Barao, Isabel, Riordan, William, Sitcheran, Raquel, Wysocki, Christian, Serody, Jonathan S., Blazar, Bruce R., Sayers, Thomas J., Murphy, William J.
Izdano 2004

2015 Proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine Symposium

od Spitalnik, Steven L., Triulzi, Darrell, Devine, Dana V., Dzik, Walter H., Eder, Anne F., Gernsheimer, Terry, Josephson, Cassandra D., Kor, Daryl J., Luban, Naomi L. C., Roubinian, Nareg H., Mondoro, Traci, Welniak, Lisbeth A., Zou, Shimian, Glynn, Simone
izdano v Transfusion (2015)

Cell Therapy Product Administration and Safety: Data Capture and Analysis from the Production Assistance for Cellular Therapies (PACT) Program

od Lindblad, Robert W., Ibenana, Laarni, Wagner, John E., McKenna, David H., Hei, Derek J., Hematti, Peiman, Couture, Larry A., Silberstein, Leslie E., Armant, Myriam, Rooney, Cliona M., Gee, Adrian P., Welniak, Lisbeth A., Mondoro, Traci Heath, Wood, Deborah A., Styers, David
izdano v Transfusion (2014)